16-67198781-A-G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_001950.4(E2F4):​c.*658A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 213,958 control chromosomes in the GnomAD database, including 1,948 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.12 ( 1773 hom., cov: 33)
Exomes 𝑓: 0.055 ( 175 hom. )

Consequence

E2F4
NM_001950.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 3.37

Publications

23 publications found
Variant links:
Genes affected
E2F4 (HGNC:3118): (E2F transcription factor 4) The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein binds to all three of the tumor suppressor proteins pRB, p107 and p130, but with higher affinity to the last two. It plays an important role in the suppression of proliferation-associated genes, and its gene mutation and increased expression may be associated with human cancer. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.264 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
E2F4NM_001950.4 linkc.*658A>G 3_prime_UTR_variant Exon 10 of 10 ENST00000379378.8 NP_001941.2 Q16254

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
E2F4ENST00000379378.8 linkc.*658A>G 3_prime_UTR_variant Exon 10 of 10 1 NM_001950.4 ENSP00000368686.3 Q16254
E2F4ENST00000567007.5 linkn.2479A>G non_coding_transcript_exon_variant Exon 8 of 8 2

Frequencies

GnomAD3 genomes
AF:
0.120
AC:
18276
AN:
152066
Hom.:
1767
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.268
Gnomad AMI
AF:
0.115
Gnomad AMR
AF:
0.0544
Gnomad ASJ
AF:
0.0257
Gnomad EAS
AF:
0.00848
Gnomad SAS
AF:
0.0917
Gnomad FIN
AF:
0.121
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0618
Gnomad OTH
AF:
0.0879
GnomAD4 exome
AF:
0.0553
AC:
3415
AN:
61774
Hom.:
175
Cov.:
0
AF XY:
0.0547
AC XY:
1736
AN XY:
31760
show subpopulations
African (AFR)
AF:
0.214
AC:
317
AN:
1482
American (AMR)
AF:
0.0439
AC:
166
AN:
3780
Ashkenazi Jewish (ASJ)
AF:
0.0210
AC:
38
AN:
1806
East Asian (EAS)
AF:
0.00762
AC:
29
AN:
3808
South Asian (SAS)
AF:
0.0739
AC:
408
AN:
5520
European-Finnish (FIN)
AF:
0.0798
AC:
205
AN:
2570
Middle Eastern (MID)
AF:
0.0227
AC:
6
AN:
264
European-Non Finnish (NFE)
AF:
0.0524
AC:
2044
AN:
39034
Other (OTH)
AF:
0.0575
AC:
202
AN:
3510
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
157
315
472
630
787
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.120
AC:
18307
AN:
152184
Hom.:
1773
Cov.:
33
AF XY:
0.121
AC XY:
8997
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.268
AC:
11109
AN:
41492
American (AMR)
AF:
0.0543
AC:
831
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0257
AC:
89
AN:
3468
East Asian (EAS)
AF:
0.00869
AC:
45
AN:
5176
South Asian (SAS)
AF:
0.0920
AC:
444
AN:
4828
European-Finnish (FIN)
AF:
0.121
AC:
1285
AN:
10596
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0618
AC:
4204
AN:
68008
Other (OTH)
AF:
0.0879
AC:
186
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
773
1546
2320
3093
3866
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0830
Hom.:
2340
Bravo
AF:
0.120
Asia WGS
AF:
0.0840
AC:
293
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
20
DANN
Benign
0.89
PhyloP100
3.4
PromoterAI
0.011
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11700; hg19: chr16-67232684; API